Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Diego
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
University of Washington
Thomas Jefferson University
Dana-Farber Cancer Institute
University of California, San Diego
M.D. Anderson Cancer Center
University of California, San Diego
M.D. Anderson Cancer Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
University of Utah
University of Miami
Masonic Cancer Center, University of Minnesota
Northwestern University
Mayo Clinic
Thomas Jefferson University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
University of Rochester
M.D. Anderson Cancer Center
Academic and Community Cancer Research United
University of Rochester
University of California, San Diego
City of Hope Medical Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center